Samira Mohammadi-Yeganeh

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Venues

Journal of cellular physiology

Journal of cellular biochemistry

Cancer immunology, immunotherapy : CII

Molecular biology reports

Shahid Beheshti University of Medical Sciences

Pasteur Institute of Iran (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shahid Beheshti University of Medical Sciences Feb 14 2013

Iran

Assistant-Professor :: Biotechnology

Education History

Pasteur Institute of Iran Feb 03 2009 - May 10 2013

Iran

PHD :: Biotechnology

Tehran University of Medical Sciences Sep 22 2011 - Feb 01 2013

Iran

MSC :: Medical Micrpbiology

Alzahra University Sep 22 2006 - Feb 01 2010

Iran

BSC :: Mocrobiology

Publications

Javad Razaviyan, Majid Sirati-Sabet, Ali Tafti, Razie Hadavi, Saeed Karima, Masumeh Rajabi Bazl, Samira Mohammadi-Yeganeh
Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate PTEN in Triple Negative Breast Cancer. Endocrine, metabolic & immune disorders drug targets (2024)
Ali Tafti, Samaneh Shojaei, Hakimeh Zali, Saeed Karima, Samira Mohammadi-Yeganeh, Mahdieh Mondanizadeh
A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells. Molecular carcinogenesis (2023)
Majdedin Ghalavand, Maryam Moradi-Chaleshtori, Roohollah Dorostkar, Samira Mohammadi-Yeganeh, Seyed Mahmoud Hashemi
Exosomes derived from rapamycin-treated 4T1 breast cancer cells induced polarization of macrophages to M1 phenotype. Biotechnology and applied biochemistry (2023)
Ali Ahmadizad Firouzjaei, Seyed Hamid Aghaee-Bakhtiari, Ali Tafti, Kazem Sharifi, Mohammad Hassan Jafari Najaf Abadi, Samaneh Rezaei, Samira Mohammadi-Yeganeh
Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies. Cell biochemistry and function (2023)
Fateme Arjmand, Samaneh Shojaei, Mitra Khalili, Hossein Dinmohammadi, Behzad Poopak, Samira Mohammadi-Yeganeh, Yousef Mortazavi
Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL). BioImpacts : BI 14 (4) (2023)
Sara Anajafi, Mahdi Paryan, Amineh Khoshnazar, Masoud Soleimani, Samira Mohammadi-Yeganeh
miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment. Endocrine, metabolic & immune disorders drug targets (2023)
Vahedeh Hosseini, Mahdi Paryan, Ameneh Koochaki, Henry Manuel Cesaire, Samira Mohammadi-Yeganeh
Mir-4699 promotes the osteogenic differentiation of mesenchymal stem cells. Journal of bone and mineral metabolism (2023)
Fateme Arjmand, Samaneh Shojaei, Mitra Khalili, Hossein Dinmohammadi, Behzad Poopak, Samira Mohammadi-Yeganeh, Yousef Mortazavi
Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL). BioImpacts : BI 14 (4) (2023)
Jafar Poodineh, Majid Sirati-Sabet, Masumeh Rajabi Bazl, Majid Ghasemian, Samira Mohammadi-Yeganeh
Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p. Chemical biology & drug design 100 (3) (2022)
Vahid Kia, Ali Tafti, Mahdi Paryan, Samira Mohammadi-Yeganeh
Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR. Irish journal of medical science (2022)
Samaneh Shojaei, Seyed Mahmoud Hashemi, Hossein Ghanbarian, Kazem Sharifi, Mohammad Salehi, Samira Mohammadi-Yeganeh
Delivery of miR-381-3p Mimic by Mesenchymal Stem Cell-Derived Exosomes Inhibits Triple Negative Breast Cancer Aggressiveness; an In Vitro Study. Stem cell reviews and reports 17 (3) (2021)
Shaghayegh Pishkari, Razie Hadavi, Ameneh Koochaki, Javad Razaviyan, Mahdi Paryan, Mehrdad Hashemi, Samira Mohammadi-Yeganeh
Assessment of AXL and mTOR genes expression in medullary thyroid carcinoma (MTC) cell line in relation with over expression of miR-144 and miR-34a. Hormone molecular biology and clinical investigation 42 (3) (2021)
Maryam Moradi-Chaleshtori, Mojgan Bandehpour, Sara Soudi, Samira Mohammadi-Yeganeh, Seyed Mahmoud Hashemi
In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes. Cancer immunology, immunotherapy : CII 70 (5) (2020)
Maryam Moradi-Chaleshtori, Mojgan Bandehpour, Sara Soudi, Samira Mohammadi-Yeganeh, Seyed Mahmoud Hashemi
Correction to: In vitro and in vivo evaluation of anti‑tumoral effect of M1 phenotype induction in macrophages by miR‑130 and miR‑33 containing exosomes. Cancer immunology, immunotherapy : CII (2020)
Zohreh Karimi, Ehsan Seyedjafari, Arash Khojasteh, Seyed Mahmoud Hashemi, Bahram Kazemi, Samira Mohammadi-Yeganeh
MicroRNA-218 competes with differentiation media in the induction of osteogenic differentiation of mesenchymal stem cell by regulating β-catenin inhibitors. Molecular biology reports 47 (11) (2020)
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan
Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma. Molecular biology reports 47 (10) (2020)
Samira Mohammadi-Yeganeh, Vahedeh Hosseini, Mahdi Paryan
Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo. Journal of cellular physiology 234 (10) (2019)
Maryam Musavi, Fatemeh Kohram, Mozhgan Abasi, Zohreh Bolandi, Mohammad Ajoudanian, Samira Mohammadi-Yeganeh, Seyed Mahmoud Hashemi, Kazem Sharifi, Hamid Reza Fathi, Hossein Ghanbarian
Rn7SK small nuclear RNA is involved in cellular senescence. Journal of cellular physiology 234 (8) (2019)
Hamidreza Houri, Zohreh Ghalavand, Ebrahim Faghihloo, Fatemeh Fallah, Samira Mohammadi-Yeganeh
Exploiting yoeB-yefM toxin-antitoxin system of Streptococcus pneumoniae on the selective killing of miR-21 overexpressing breast cancer cell line (MCF-7). Journal of cellular physiology 235 (3) (2019)
Noushin Shabani, Sara Sheikholeslami, Mahdi Paryan, Marjan Zarif Yeganeh, Seyed Mohammad Tavangar, Fereidoun Azizi, Samira Mohammadi-Yeganeh, Mehdi Hedayati
An investigation on the expression of miRNAs including miR-144 and miR-34a in plasma samples of RET-positive and RET-negative medullar thyroid carcinoma patients. Journal of cellular physiology 235 (2) (2019)
Mohammad-Nazir Menbari, Karim Rahimi, Abbas Ahmadi, Samira Mohammadi-Yeganeh, Anvar Elyasi, Nikoo Darvishi, Vahedeh Hosseini, Mohammad Abdi
miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene. Journal of cellular physiology 235 (3) (2019)
Vida Pourteimoor, Mahdi Paryan, Samira Mohammadi-Yeganeh
microRNA as a systemic intervention in the specific breast cancer subtypes with C-MYC impacts; introducing subtype-based appraisal tool. Journal of cellular physiology 233 (8) (2018)
Vahedeh Hosseini, Samira Mohammadi-Yeganeh, Hossein Ghanbarian, Seyed Mahmoud Hashemi, Arash Khojasteh
The power of precise bioinformatics prediction of miRNA:mRNA interactions:miR-4699 as a potential inducer of Wnt signaling pathway. Journal of cellular biochemistry 119 (7) (2018)
Maryam Moradi-Chaleshtori, Seyed Mahmoud Hashemi, Sara Soudi, Mojgan Bandehpour, Samira Mohammadi-Yeganeh
Tumor-derived exosomal microRNAs and proteins as modulators of macrophage function. Journal of cellular physiology 234 (6) (2018)
Vahid Kia, Mahdi Paryan, Yousef Mortazavi, Alireza Biglari, Samira Mohammadi-Yeganeh
Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells. Journal of cellular biochemistry 120 (4) (2018)
Samaneh Shojaei, Seyed Mahmoud Hashemi, Hossein Ghanbarian, Mohammad Salehi, Samira Mohammadi-Yeganeh
Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: Tumor progression versus tumor suppression. Journal of cellular physiology 234 (4) (2018)

Samira Mohammadi-Yeganeh.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Samira Mohammadi-Yeganeh